Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022

Suzanne Cuda , Marisa Censani , Roohi Kharofa , Valerie O'Hara , Rushika Conroy , Dominique R. Williams , Jennifer Paisley , Allen F. Browne , Sara Karjoo , Nancy T. Browne
{"title":"Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022","authors":"Suzanne Cuda ,&nbsp;Marisa Censani ,&nbsp;Roohi Kharofa ,&nbsp;Valerie O'Hara ,&nbsp;Rushika Conroy ,&nbsp;Dominique R. Williams ,&nbsp;Jennifer Paisley ,&nbsp;Allen F. Browne ,&nbsp;Sara Karjoo ,&nbsp;Nancy T. Browne","doi":"10.1016/j.obpill.2022.100048","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details medication-induced weight gain and advanced therapies for the child with overweight or obesity.</p></div><div><h3>Methods</h3><p>The scientific information and clinical guidance in this CPS are based on scientific evidence, supported by the medical literature, and derived from the clinical perspectives of the authors.</p></div><div><h3>Results</h3><p>This OMA Clinical Practice Statement addresses medication-induced weight gain and advanced therapies for the child with overweight or obesity.</p></div><div><h3>Conclusions</h3><p>This OMA Clinical Practice Statement on medication induced-weight gain and advanced therapies for the child with overweight or obesity is an overview of current recommendations. These recommendations provide a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications. This CPS also addresses treatment recommendations. This section is designed to help the provider with clinical decision making.</p></div>","PeriodicalId":100977,"journal":{"name":"Obesity Pillars","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667368122000390/pdfft?md5=0c2f36f0e6b5e6903678cbd8827b55a3&pid=1-s2.0-S2667368122000390-main.pdf","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Pillars","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667368122000390","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Background

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details medication-induced weight gain and advanced therapies for the child with overweight or obesity.

Methods

The scientific information and clinical guidance in this CPS are based on scientific evidence, supported by the medical literature, and derived from the clinical perspectives of the authors.

Results

This OMA Clinical Practice Statement addresses medication-induced weight gain and advanced therapies for the child with overweight or obesity.

Conclusions

This OMA Clinical Practice Statement on medication induced-weight gain and advanced therapies for the child with overweight or obesity is an overview of current recommendations. These recommendations provide a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications. This CPS also addresses treatment recommendations. This section is designed to help the provider with clinical decision making.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
超重和肥胖儿童的药物诱导体重增加和先进疗法:肥胖医学协会(OMA)临床实践声明2022
这份肥胖医学协会(OMA)临床实践声明(CPS)详细介绍了药物引起的体重增加和超重或肥胖儿童的先进治疗方法。方法本指南的科学信息和临床指导以科学证据为基础,以医学文献为支撑,并从作者的临床角度出发。本OMA临床实践声明涉及药物引起的体重增加和超重或肥胖儿童的先进治疗。本OMA临床实践声明对超重或肥胖儿童的药物诱导体重增加和先进疗法进行了概述。这些建议为改善肥胖儿童和青少年的健康,特别是那些有代谢、生理和心理并发症的儿童和青少年的健康提供了路线图。该CPS还提出了治疗建议。本节旨在帮助提供者进行临床决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Efficacy of in-person versus digital enhanced lifestyle interventions in adults with overweight and obesity Effect of resveratrol supplementation on metabolic risk markers and anthropometric parameters in individuals with obesity or overweight: A systematic review and meta-analysis of randomized controlled trials Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review Case report of a female western Indian vegetarian with obesity Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1